Inhibition by uridine but not thymidine of p53-dependent intestinal apoptosis initiated by 5-fluorouracil: Evidence for the involvement of RNA perturbation

Proceedings of the National Academy of Sciences of the United States of America

Volumn 94, Issue 5, 1997, Pages 1795-1799

  Pritchard, Mark ^a,b   Watson, Alastair J M ^b   Potten, Christopher S ^a   Jackman, Ann L ^c   Hickman, John A ^b  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

epithelia

Indexed keywords

FLUOROURACIL; FOLINIC ACID; PROTEIN P53; RALTITREXED; RNA; THYMIDINE; THYMIDYLATE SYNTHASE; URIDINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; CONFERENCE PAPER; CONTROLLED STUDY; DNA DAMAGE; GAMMA IRRADIATION; INTESTINE CRYPT; INTESTINE EPITHELIUM CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 12644291915     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.94.5.1795     Document Type: Article

References (27)

1. Lane, D. P. (1992) Nature (London) 358, 15-16.
2. Yonish-Rouach, E., Resnitzky, D., Lotem, J., Sachs, L., Kimchi, A. & Oren, M. (1991) Nature (London) 353, 345-347.
3. Wu, L., Bayle, J. H., Elenbaas, B., Pavletich, N. P. & Levine, A. J. (1995) Mol. Cell. Biol. 15, 497-504.
4. Potten, C. S. (1992) Cancer Metastasis Rev. 11, 179-195.
5. Potten, C. S. (1995) in Radiation and Gut, eds. Potten, C. S. & Hendry, J. H. (Elsevier Science, Amsterdam), pp. 1-31.
6. Merritt, A. J., Potten, C. S., Kemp, C. J., Hickman, J. A., Ballmain, A., Lane, D. P. & Hall, P. A. (1994) Cancer Res. 54, 614-617.
7. Ijiri, K. & Potten, C. S. (1983) Br. J. Cancer 47, 175-185.
8. Ijiri, K. & Potten, C. S. (1987) Br. J. Cancer 55, 113-123.
9. Curtin, N. J., Harris, A. L. & Aherne, G. W. (1991) Cancer Res. 51, 2346-2352.
10. Parker, W. B. & Cheng, Y. C. (1990) Pharmacol. Ther. 48, 381-395.
11. Houghton, J. A., Houghton, P. J. & Wooten, R. S. (1979) Cancer Res. 39, 2406-2413.
12. Geoffroy, F. J., Allegra, C. J., Sinha, B. & Grem, J. L. (1994) Oncol. Res. 6, 581-591.
13. Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Jr., Butel, J. S. & Bradley, A. (1992) Nature (London) 356, 215-221.
14. Merritt, A. J., Potten, C. S., Watson, A. J. M., Loh, D. Y., Nakayama, K., Nakayama, K. & Hickman, J. A. (1995) J. Cell Sci. 108, 2261-2271.
15. Li, Y. Q., Fan, C. Y., O'Connor, P. J., Winton, D. J. & Potten, C. S. (1992) Carcinogenesis 13, 361-368.
16. Merritt, A. J., Jones, L. S. & Potten, C. S. (1996) in Techniques in Apoptosis, eds. Cotter, T. G. & Martin, S. J. (Portland Press, London), pp. 269-300.
17. Jackman, A. L., Farrugia, D. C., Gibson, W., Kimbell, R., Harrap, K. R., Stephens, T. C., Azab, M. & Boyle, F. T. (1995) Eur. J. Cancer 31, 1277-1282.
18. Peters, G. J. (1995) in The Scientific Basis for Cancer Treatment, eds. Peckham, M., Pinedo, H. & Veronesi, U. (Oxford Univ. Press, Oxford), pp. 524-552.
19. Floch, M. H. & Hellman, L. (1965) Gastroenterology 48, 430-437.
20. Klubes, P. & Leyland-Jones, B. (1989) Pharmacol. Ther. 41, 289-302.
21. Bagrij, T., Kralovansky, J., Gyergyay, F., Kiss, E. & Peters, G. J. (1993) Anticancer Res. 13, 789-794.
22. Martin, D. S., Stoffi, R. L., Sawyer, R. C., Spiegelman, S. & Young, C. W. (1982) Cancer Res. 42, 3964-3970.
23. Kralovansky, J., Prajda, N., Kerpel-Fronius, S., Bagrij, T., Kiss, E. & Peters, G. J. (1993) Cancer Chemother. Pharmacol. 32, 243-248.
24. Linke, S. P., Clarkin, K. C., Di Leonardo, A., Tsou, A. & Wahl, G. M. (1996) Genes Dev. 10, 934-947.
25. Fontoura, B. M. A., Sorokina, E. A., David, E. & Carroll, R. B. (1992) Mol. Cell. Biol. 12, 5145-5151.
26. Marechal, V. B., Elenbas, J., Piette, J. C., Nicolas, J. C. & Levine, A. J. (1994) Mol. Cell. Biol. 14, 7414-7420.
27. Yamaizumi, M. & Sugano, T. (1994) Oncogene 9, 2775-2784.